Latest receivables for RMTI: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), RMTI shows a receivables of $0. That compares with $9.7M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, RMTI's receivables is now $0 (was $9.7M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rockwell Medical is outperforming or lagging.
Tracking RMTI's receivables over time shows whether Rockwell Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $9.7M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Rockwell Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.
Rockwell Medical's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.